This is the authors' abstract. We don't add key points for this paper.
Cryptosporidium is a protozoan parasite that causes gastrointestinal disease in humans and animals. Currently, there is a limited array of antibodies available against the parasite, which hinders imaging studies and makes it difficult to visualize the parasite life cycle in different culture systems. In order to alleviate this reagent gap, we created a library of novel antibodies against the intracellular life cycle stages of Cryptosporidium . We identified antibodies that recognize specific life cycle stages in distinctive ways, enabling unambiguous description of the parasite life cycle. These MAbs will aid future investigation into Cryptosporidium biology and help illuminate growth differences between various culture platforms.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wilke et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: